Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 10180Triple Negative Breast Neoplasms 1045Neoplasms 573Ovarian Neoplasms 564Neoplasm Metastasis 515Colorectal Neoplasms 472Carcinoma, Non-Small-Cell Lung 467Prostatic Neoplasms 440Lung Neoplasms 433Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 295Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 227Endometrial Neoplasms 223Head and Neck Neoplasms 218Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 192Squamous Cell Carcinoma of Head and Neck 181Sarcoma 176Urinary Bladder Neoplasms 159Esophageal Neoplasms 155Brain Neoplasms 155Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 130

Interventions

Tamoxifen 2palbociclib 1exemestane 1elacestrant 1Letrozole 1Fulvestrant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × ER+ Breast Cancer × Breast × Clear all
NCT06923527 2026-05-12

Circulating Tumor DNA

Yale University

Phase 2 Recruiting
50 enrolled
Breast

ER+ Breast Cancer

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting
1,100 enrolled
Breast

ER+ Breast Cancer

NCT04824014 2024-02-06

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Phase 2 Unknown
150 enrolled
Breast

ER+ Breast Cancer

NCT05525481 2023-11-01

PREDICTAM

Erasmus Medical Center

Phase 4 Unknown
100 enrolled
Breast

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡